HASTACA
ActiveSummary
HASTACA has been active since 2010 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €518,472 and a net result of €139,787. Equity is growing by ~12.3% per year across the filed fiscal years. Its solvency ranks better than 66% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability95▲+2
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €45,000 at 30 days acceptable
Liquidity ample (current ratio 1.54 against 0.9 in 2024; short-term debt: 15.6% and cash: 9.5% of total assets), and 22.1% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
77.9%
Return on assets
21%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-08-2026, 27 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
27 d late
2024
27 d late
2023
1 d early
2022
29 d late
2021
30 d late
2020
23 d early
2019
14 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 11 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€518,472▲ 16.9%
2024 · €443,335
Total assets
€665,169▲ 13.5%
2024 · €586,242
Net result
€139,787▲ 21.9%
2024 · €114,664
Working capital
€56,621
2024 · -€14,269
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€138,365▲ 83.1%€142,648▲ 3.1%€166,258▲ 16.6%€175,187▲ 5.4%€210,034▲ 19.9%
Net result€46,912within the sector's middle half▲ 17.1%€56,249within the sector's middle half▲ 19.9%€108,125above the sector's middle half▲ 92.2%€114,664within the sector's middle half▲ 6.0%€139,787above the sector's middle half▲ 21.9%
Equity€262,588within the sector's middle half▼ 18.7%€317,237within the sector's middle half▲ 20.8%€395,263above the sector's middle half▲ 24.6%€443,335above the sector's middle half▲ 12.2%€518,472above the sector's middle half▲ 16.9%
Total assets€637,268above the sector's middle half▼ 5.5%€642,359above the sector's middle half▲ 0.8%€637,528above the sector's middle half▼ 0.8%€586,242within the sector's middle half▼ 8.0%€665,169above the sector's middle half▲ 13.5%
Debt€374,680▲ 6.6%€325,123▼ 13.2%€242,265▼ 25.5%€142,907▼ 41.0%€146,697▲ 2.7%
Working capital-€60,105below the sector's middle half-€41,942below the sector's middle half▲ 30.2%-€2,495below the sector's middle half▲ 94.1%-€14,269below the sector's middle half▼ 472%€56,621within the sector's middle half
Solvency41.2%within the sector's middle half▼ 6.7pp49.4%within the sector's middle half▲ 8.2pp62.0%within the sector's middle half▲ 12.6pp75.6%within the sector's middle half▲ 13.6pp77.9%within the sector's middle half▲ 2.3pp
Current ratio0.63below the sector's middle half▼ 1.050.77below the sector's middle half▲ 0.140.99below the sector's middle half▲ 0.210.90below the sector's middle half▼ 0.081.54within the sector's middle half▲ 0.64
Return on assets (ROA)7.4%below the sector's middle half▲ 1.4pp8.8%within the sector's middle half▲ 1.4pp17.0%within the sector's middle half▲ 8.2pp19.6%within the sector's middle half▲ 2.6pp21.0%within the sector's middle half▲ 1.5pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen four years in a row; 2025 is 20% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €665,169
Fixed assets
€504,638 ▲ 10.3%
Current assets
€160,531 ▲ 24.8%
Equity and liabilities €665,169
Equity
€518,472 ▲ 16.9%
Debt
€146,697 ▲ 2.7%
Debt's share of the balance-sheet total falls from 24.4% to 22.1%. Equity and debt are higher.
Key figures and ratios
EBITDA
€242,934▲
2024 · €204,334
Cash flow
€172,687▲
2024 · €143,811
Debt to equity
0.28▼
2024 · 0.32
ROE
27.0%▲
2024 · 25.9%
Interest coverage
26.17▲
2024 · 17.92
Debt ≤ 1 year
€103,910▼
2024 · €142,907
Debt > 1 year
€42,788▲
2024 · €0
Income taxes
€60,964▲
2024 · €49,124
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 17,810 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 97% are still going.
- Small
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.2%
went bankrupt
3.1%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,810 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €29,407 | €33,805 | €33,581 | €29,147 | €32,900 | ▲ 12.9% |
| Other operating charges640/8 | €1,472 | €1,639 | €3,006 | €4,853 | €2,107 | ▼ 56.6% |
| Gross operating margin9900 | €169,243 | €178,093 | €202,844 | €209,188 | €245,040 | ▲ 17.1% |
| Operating profit (loss)9901 | €138,365 | €142,648 | €166,258 | €175,187 | €210,034 | ▲ 19.9% |
| Financial income75/76B | €68 | - | €1 | €1 | €1 | ▲ 42.9% |
| Recurring financial income75 | €68 | - | €1 | €1 | €1 | ▲ 42.9% |
| Financial charges65/66B | €72,740 | €64,553 | €12,008 | €11,400 | €9,284 | ▼ 18.6% |
| Recurring financial charges65 | €72,740 | €64,553 | €12,008 | €11,400 | €9,284 | ▼ 18.6% |
| Profit (loss) for the period before taxes9903 | €65,694 | €78,095 | €154,251 | €163,788 | €200,751 | ▲ 22.6% |
| Income taxes67/77 | €18,782 | €21,846 | €46,126 | €49,124 | €60,964 | ▲ 24.1% |
| Profit (loss) for the period9904 | €46,912 | €56,249 | €108,125 | €114,664 | €139,787 | ▲ 21.9% |
| Profit (loss) for the period to be appropriated9905 | €46,912 | €56,249 | €108,125 | €114,664 | €139,787 | ▲ 21.9% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €637,268 | €642,359 | €637,528 | €586,242 | €665,169 | ▲ 13.5% |
| Fixed assets21/28 | €534,928 | €501,123 | €473,251 | €457,604 | €504,638 | ▲ 10.3% |
| Tangible fixed assets22/27 | €534,928 | €501,123 | €473,251 | €457,604 | €504,638 | ▲ 10.3% |
| Land and buildings22 | €523,284 | €495,503 | €473,185 | €454,736 | €443,239 | ▼ 2.5% |
| Furniture and vehicles24 | €11,644 | €5,619 | €66 | €2,868 | €61,400 | ▲ 2,041% |
| Current assets29/58 | €102,340 | €141,237 | €164,277 | €128,638 | €160,531 | ▲ 24.8% |
| Amounts receivable within one year40/41 | €83,987 | €83,891 | €89,887 | €92,693 | €97,333 | ▲ 5.0% |
| Trade receivables40 | €77,701 | €77,673 | €89,887 | €91,817 | €96,457 | ▲ 5.1% |
| Other amounts receivable41 | €6,286 | €6,218 | - | €876 | €876 | = |
| Cash at bank and in hand54/58 | €18,353 | €53,793 | €74,390 | €35,945 | €63,198 | ▲ 75.8% |
| Deferred charges and accrued income490/1 | - | €3,552 | - | - | - | - |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €637,268 | €642,359 | €637,528 | €586,242 | €665,169 | ▲ 13.5% |
| Equity10/15 | €262,588 | €317,237 | €395,263 | €443,335 | €518,472 | ▲ 16.9% |
| Contributions10/11 | €12,400 | €12,400 | €12,400 | €12,400 | €12,400 | = |
| Reserves13 | €250,188 | €304,837 | €382,863 | €430,935 | €506,072 | ▲ 17.4% |
| Non-distributable reserves130/1 | €1,860 | €1,860 | - | - | - | - |
| Reserves not available under the articles1311 | €1,860 | €1,860 | - | - | - | - |
| Distributable reserves133 | €248,328 | €302,977 | €382,863 | €430,935 | €506,072 | ▲ 17.4% |
| Profit (loss) carried forward14 | - | - | - | €0 | €0 | - |
| Amounts payable17/49 | €374,680 | €325,123 | €242,265 | €142,907 | €146,697 | ▲ 2.7% |
| Amounts payable after more than one year17 | €212,235 | €141,943 | €69,099 | €0 | €42,788 | - |
| Financial debts170/4 | €212,235 | €141,943 | €69,099 | €0 | €42,788 | - |
| Amounts payable within one year42/48 | €162,444 | €183,179 | €166,772 | €142,907 | €103,910 | ▼ 27.3% |
| Current portion of amounts payable after more than one year42 | €67,829 | €70,292 | €72,845 | €69,099 | €15,668 | ▼ 77.3% |
| Trade debts44 | €7,301 | €7,158 | €7,605 | €3,698 | €5,757 | ▲ 55.7% |
| Suppliers440/4 | €7,301 | €7,158 | €7,605 | €3,698 | €5,757 | ▲ 55.7% |
| Taxes, remuneration and social security45 | €981 | €2,904 | €9,774 | €10,355 | €8,000 | ▼ 22.7% |
| Taxes450/3 | €981 | €2,904 | €9,774 | €10,355 | €8,000 | ▼ 22.7% |
| Other amounts payable47/48 | €86,334 | €102,825 | €76,548 | €59,757 | €74,484 | ▲ 24.6% |
| Accrued charges and deferred income492/3 | - | - | €6,394 | €0 | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €46,912 | €56,249 | €108,125 | €114,664 | €139,787 | ▲ 21.9% |
| + Depreciation and write-downs630 | €29,407 | €33,805 | €33,581 | €29,147 | €32,900 | ▲ 12.9% |
| Operating cash flow (approximation) | €76,318 | €90,054 | €141,706 | €143,811 | €172,687 | ▲ 20.1% |
| Investment in fixed assets (approximation) | - | €0 | -€5,709 | -€13,501 | -€79,934 | ▼ 492% |
| Change in cash | - | €35,440 | €20,597 | -€38,445 | €27,252 | ▲ 171% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 27 days late
2025
31-12
Financial
Highest result since 2018net €139,787 ▲21.9%
Operating result €210,034, net result €139,787, both a record.
31-12
Financial
Equity above €500,000Eq €518,472 ▲16.9%
8 profitable years in a row build equity to €518,472.
27-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 27 days late
2024
30-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 29 days late
2022
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
2021
08-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Weakest financial yearnet €40,076 ▼38%
Net result drops to €40,076, the lowest in the series; recovery starts the following year.
17-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
19-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
20-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
04-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 5 acts read
About the unread acts
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
5 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Westerlo · 1 establishment unit since 2010
Ground area
4,677 m²
Building footprint
205 m²
Volume, LiDAR
1,239 m³
Parcel 13039C0051/00C000, Flanders · tallest building 10.8 m, ±2 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
DR. ESTHER VAN SOMMEREN
since 20102.301.684.987
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13039C0051/00C000 | Flanders | 4,677 m² | 1 · 205 m² | 10.8 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
549300QL10059W1VFT52
Similar companies · same sector, comparable size
DR. HEYSE ALEX, CARDIOLOOG
BE 0844.778.047
Kluisbergen · Eq €518,535
Dr. Ann Vandenbroucke
BE 0878.156.044
Jabbeke · Eq €518,728
JACQUES JANI
BE 0815.846.214
Waterloo · Eq €518,177
GRANDA
BE 0801.364.015
Aalst · Eq €518,126
ENDODERM
BE 0655.942.209
Pont-à-Celles · Eq €518,959
Of 16,631 companies in sector 86220 we hold annual accounts for 7,985. 6,412 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded11-01-2010
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0822164179
Also
9925:BE0822164179
Registered
17-12-2025
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.